Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID‐19

BACKGROUND: To explore the association of thrombo‐inflammatory biomarkers with severity in coronavirus disease (COVID‐19), we measured antiphospholipid antibodies (aPL) and calprotectin in sera of COVID‐19 patients. METHODS: Anticardiolipin antibodies (aCL) and anti‐β2‐glycoprotein I antibodies were...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Anna, Nahm, Chung Hyun, Lee, Jin‐Soo, Lee, Mi‐Kyeong, Lee, Kyoung‐Ryul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605160/
https://www.ncbi.nlm.nih.gov/pubmed/34608677
http://dx.doi.org/10.1002/jcla.24004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605160/
https://www.ncbi.nlm.nih.gov/pubmed/34608677
http://dx.doi.org/10.1002/jcla.24004

Ejemplares similares